Thermo Fisher Scientific
TMO
2,376 hedge funds and large institutions have $189B invested in Thermo Fisher Scientific in 2022 Q4 according to their latest regulatory filings, with 236 funds opening new positions, 873 increasing their positions, 926 reducing their positions, and 78 closing their positions.
203% more first-time investments, than exits
New positions opened: 236 | Existing positions closed: 78
17% more call options, than puts
Call options by funds: $1.84B | Put options by funds: $1.58B
8% more capital invested
Capital invested by funds: $175B → $189B (+$13.8B)
5% more funds holding
Funds holding: 2,268 → 2,376 (+108)
0.73% less ownership
Funds ownership: 88.24% → 87.51% (-0.73%)
6% less repeat investments, than reductions
Existing positions increased: 873 | Existing positions reduced: 926
1% less funds holding in top 10
Funds holding in top 10: 239 → 236 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Polen Capital Management
Boca Raton,
Florida
|
+$1.16B |
| 2 |
Morgan Stanley
New York
|
+$935M |
| 3 |
Jennison Associates
New York
|
+$212M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$195M |
| 5 |
Barclays
London,
United Kingdom
|
+$183M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$847M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$397M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$374M |
| 4 |
ClearBridge Investments
New York
|
-$299M |
| 5 |
Goldman Sachs
New York
|
-$221M |
TMO Hedge Fund Activity: Q4 2022 in Review
2,376 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2022, worth a combined $189B — up 7.9% from $175B a quarter earlier.
Buyers outnumbered sellers: 236 funds opened new TMO positions and 78 closed out — a net gain of 158 holders — while 873 added to existing stakes and 926 trimmed.
The largest buyer was Polen Capital Management, opening a new position worth an estimated $1.16B. The largest seller was Capital Research Global Investors, cutting an estimated $847M.
- 2,376 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2022, up from 2,268 in Q3 2022.
- Funds reported $189B of Thermo Fisher Scientific stock for Q4 2022, up 7.9% quarter-over-quarter.
- 236 funds opened new Thermo Fisher Scientific positions in Q4 2022 and 78 closed out, a net change of +158 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2022 was Polen Capital Management, an estimated $1.16B added.
- The largest Thermo Fisher Scientific seller in Q4 2022 was Capital Research Global Investors, an estimated $847M sold.
Based on aggregated 13F filings for Q4 2022.